Psoriatic Arthritis Treatment Market to Reach USD 25,375.6 Million by 2034, Growing at a 7.8% CAGR

The global psoriatic arthritis (PsA) treatment market, valued at USD 11,973.7 million in 2024, is projected to experience significant growth over the next decade. With a Compound Annual Growth Rate (CAGR) of 7.8%, the market is expected to reach a valuation of USD 25,375.6 million by 2034. The growing prevalence of psoriatic arthritis, a chronic …

Global Psoriatic Arthritis Treatment Market Poised for Significant Growth, Projected to Reach USD 25,375.6 Million by 2034

The global psoriatic arthritis (PsA) treatment market is slated to have a valuation of USD 11,973.7 million in 2024. The need for treatment related to psoriatic arthritis arises as the count of psoriasis-affected people rises. The effects caused due to the disorder, such as morning stiffness and nail pitting, often leave patients with no recourse …

Psoriatic Arthritis Treatment Market Forecasted to Reach US$ 15.6 Billion by 2028: A Confluence of Science and Patient-Centric Solutions | FMI

The Psoriatic Arthritis (PsA) Treatment Market has been experiencing significant growth and innovation in recent years, driven by advances in medical research and a growing awareness of psoriatic arthritis among healthcare providers and patients. Psoriatic arthritis is a chronic autoimmune condition that affects individuals with psoriasis, causing inflammation, pain, and joint damage. The market for …